Skip to main content
Log in

Interrelationship Between Procalcitonin and Organ Failure in Sepsis

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Sepsis suffers from lack of specific clinical symptoms which contribute to one of the major causes of mortality. In the present study, our aim was to evaluate the role of a recent biomarker Procalcitonin (PCT) in predicting organ dysfunction. 71 patients admitted with sepsis were included in the study. PCT levels were measured at 0, 24, 72 h and 7th day and sequential organ failure assessment score (SOFA) scores were calculated. PCT levels significantly decreased (p < 0.001) in 89.3 % of surviving patients, whereas, in 60 % non surviving patients the PCT level increased significantly (p < 0.001). A significant positive correlation between PCT and SOFA score was observed in survivors at each hour. These observations indicate that PCT concentration is significantly associated with severity of multi organ dysfunction and also helps in determining the prognosis of septic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515–8.

    Article  CAS  PubMed  Google Scholar 

  2. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med. 2000;26(Suppl 2):S148–52.

    PubMed  Google Scholar 

  3. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection and sepsis: clinical utility and limitations. Crit Care Med. 2008;36(3):941–52.

    Article  CAS  PubMed  Google Scholar 

  4. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605–8.

    CAS  PubMed  Google Scholar 

  5. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro. J Lab Clin Med. 1999;134:49–55.

    Article  CAS  PubMed  Google Scholar 

  6. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396–404.

    CAS  PubMed  Google Scholar 

  7. Reinhart K, Meisner M. Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin. 2011;27:253–63.

    Article  CAS  PubMed  Google Scholar 

  8. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C reactive protein as markers of sepsis. Crit Care Med. 2003;1:1737–41.

    Article  Google Scholar 

  9. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–74.

    Google Scholar 

  10. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter prospective study. Working group on “sepsis related problems” of the European society of Intensive Care Medicine. Crit Care Med. 1998;26:1793–800.

    Article  CAS  PubMed  Google Scholar 

  11. Khilnani GC, Hadda V. Management of severe sepsis: role of “bundles”. Indian J Chest Dis Allied Sci. 2009;51:27–36.

    CAS  PubMed  Google Scholar 

  12. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. New Engl J Med. 2003;348:1546–54.

    Article  PubMed  Google Scholar 

  13. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA. 1997;278:234–40.

    Article  CAS  PubMed  Google Scholar 

  14. Anand D, Das S, Srivastava LM. Procalcitonin—a novel sepsis biomarker. Asian J Med Res. 2012;1:6–8.

    Google Scholar 

  15. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med. 2006;34:2596–602.

    Article  CAS  PubMed  Google Scholar 

  16. Rammaert B, Verdier N, Cavestri B, Nseir S. Procalcitonin as a prognostic factor in seven acute exacerbation of chronic obstructive pulmonary disease. Respirology. 2009;14:969–74.

    Article  PubMed  Google Scholar 

  17. Hillas G, Vassilakopoulos T, Plantza P, Rasidakis A, Bakakos P. C-reactive protein and procalcitonin as predictors of survival and septic shock in ventilator associated pneumonia. Eur Respir J. 2010;4:805–11.

    Article  Google Scholar 

Download references

Acknowledgments

We are grateful to Indian Council of Medical Research (ICMR), New Delhi for the sanction of a research project and financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lalit Mohan Srivastava.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anand, D., Das, S., Ray, S. et al. Interrelationship Between Procalcitonin and Organ Failure in Sepsis. Ind J Clin Biochem 29, 93–96 (2014). https://doi.org/10.1007/s12291-013-0326-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-013-0326-z

Keywords

Navigation